BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 21135270)

  • 1. Phase III comparison of prophylactic cranial irradiation versus observation in patients with locally advanced non-small-cell lung cancer: primary analysis of radiation therapy oncology group study RTOG 0214.
    Gore EM; Bae K; Wong SJ; Sun A; Bonner JA; Schild SE; Gaspar LE; Bogart JA; Werner-Wasik M; Choy H
    J Clin Oncol; 2011 Jan; 29(3):272-8. PubMed ID: 21135270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylactic Cranial Irradiation vs Observation in Patients With Locally Advanced Non-Small Cell Lung Cancer: A Long-term Update of the NRG Oncology/RTOG 0214 Phase 3 Randomized Clinical Trial.
    Sun A; Hu C; Wong SJ; Gore E; Videtic G; Dutta S; Suntharalingam M; Chen Y; Gaspar LE; Choy H
    JAMA Oncol; 2019 Jun; 5(6):847-855. PubMed ID: 30869743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase III trial of prophylactic cranial irradiation compared with observation in patients with locally advanced non-small-cell lung cancer: neurocognitive and quality-of-life analysis.
    Sun A; Bae K; Gore EM; Movsas B; Wong SJ; Meyers CA; Bonner JA; Schild SE; Gaspar LE; Bogart JA; Werner-Wasik M; Choy H
    J Clin Oncol; 2011 Jan; 29(3):279-86. PubMed ID: 21135267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prophylactic Cranial Irradiation Versus Observation in Radically Treated Stage III Non-Small-Cell Lung Cancer: A Randomized Phase III NVALT-11/DLCRG-02 Study.
    De Ruysscher D; Dingemans AC; Praag J; Belderbos J; Tissing-Tan C; Herder J; Haitjema T; Ubbels F; Lagerwaard F; El Sharouni SY; Stigt JA; Smit E; van Tinteren H; van der Noort V; Groen HJM
    J Clin Oncol; 2018 Aug; 36(23):2366-2377. PubMed ID: 29787357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prophylactic Cranial Irradiation Reduces Brain Metastases and Improves Overall Survival in High-Risk Metastatic Non-Small Cell Lung Cancer Patients: A Randomized phase 2 Study (PRoT-BM trial).
    Arrieta O; Maldonado F; Turcott JG; Zatarain-Barrón ZL; Barrón F; Blake-Cerda M; Cabrera-Miranda LA; Cardona AF; de la Garza JG; Rosell R
    Int J Radiat Oncol Biol Phys; 2021 Aug; 110(5):1442-1450. PubMed ID: 33640422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized phase III trial of prophylactic cranial irradiation versus observation in patients with fully resected stage IIIA-N2 nonsmall-cell lung cancer and high risk of cerebral metastases after adjuvant chemotherapy.
    Li N; Zeng ZF; Wang SY; Ou W; Ye X; Li J; He XH; Zhang BB; Yang H; Sun HB; Fang Q; Wang BX
    Ann Oncol; 2015 Mar; 26(3):504-9. PubMed ID: 25515658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylactic cranial irradiation in locally advanced non-small cell lung cancer: outcome of recursive partitioning analysis group 1 patients.
    Yavuz AA; Topkan E; Onal C; Yavuz MN
    J Exp Clin Cancer Res; 2008 Dec; 27(1):80. PubMed ID: 19055787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decline in tested and self-reported cognitive functioning after prophylactic cranial irradiation for lung cancer: pooled secondary analysis of Radiation Therapy Oncology Group randomized trials 0212 and 0214.
    Gondi V; Paulus R; Bruner DW; Meyers CA; Gore EM; Wolfson A; Werner-Wasik M; Sun AY; Choy H; Movsas B
    Int J Radiat Oncol Biol Phys; 2013 Jul; 86(4):656-64. PubMed ID: 23597420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment and toxic effects of prophylactic cranial irradiation in stage II-III non-small cell lung cancer: A meta-analysis.
    Li M; Wang T; Wen P; Wang X; Wu C
    Asia Pac J Clin Oncol; 2021 Apr; 17(2):e18-e26. PubMed ID: 32761788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Individual patient data meta-analysis of prophylactic cranial irradiation in locally advanced non-small cell lung cancer.
    Witlox WJA; Ramaekers BLT; Lacas B; Le Pechoux C; Pignon JP; Sun A; Wang SY; Hu C; Redman M; van der Noort V; Li N; Guckenberger M; van Tinteren H; Groen HJM; Joore MA; De Ruysscher DKM
    Radiother Oncol; 2021 May; 158():40-47. PubMed ID: 33587968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized Phase III Trial of Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance for Small-Cell Lung Cancer (PREMER): A GICOR-GOECP-SEOR Study.
    Rodríguez de Dios N; Couñago F; Murcia-Mejía M; Rico-Oses M; Calvo-Crespo P; Samper P; Vallejo C; Luna J; Trueba I; Sotoca A; Cigarral C; Farré N; Manero RM; Durán X; Gispert JD; Sánchez-Benavides G; Rognoni T; Torrente M; Capellades J; Jiménez M; Cabada T; Blanco M; Alonso A; Martínez-San Millán J; Escribano J; González B; López-Guerra JL
    J Clin Oncol; 2021 Oct; 39(28):3118-3127. PubMed ID: 34379442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized Phase II Study Comparing Prophylactic Cranial Irradiation Alone to Prophylactic Cranial Irradiation and Consolidative Extracranial Irradiation for Extensive-Disease Small Cell Lung Cancer (ED SCLC): NRG Oncology RTOG 0937.
    Gore EM; Hu C; Sun AY; Grimm DF; Ramalingam SS; Dunlap NE; Higgins KA; Werner-Wasik M; Allen AM; Iyengar P; Videtic GMM; Hales RK; McGarry RC; Urbanic JJ; Pu AT; Johnstone CA; Stieber VW; Paulus R; Bradley JD
    J Thorac Oncol; 2017 Oct; 12(10):1561-1570. PubMed ID: 28648948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Standard-dose versus higher-dose prophylactic cranial irradiation (PCI) in patients with limited-stage small-cell lung cancer in complete remission after chemotherapy and thoracic radiotherapy (PCI 99-01, EORTC 22003-08004, RTOG 0212, and IFCT 99-01): a randomised clinical trial.
    Le Péchoux C; Dunant A; Senan S; Wolfson A; Quoix E; Faivre-Finn C; Ciuleanu T; Arriagada R; Jones R; Wanders R; Lerouge D; Laplanche A;
    Lancet Oncol; 2009 May; 10(5):467-74. PubMed ID: 19386548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prophylactic Cranial Irradiation for Patients With Locally Advanced Non-Small-Cell Lung Cancer at High Risk for Brain Metastases.
    Park HS; Decker RH; Wilson LD; Yu JB
    Clin Lung Cancer; 2015 Jul; 16(4):292-7. PubMed ID: 25499149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of prophylactic cranial irradiation on survival in elderly patients with limited-stage small cell lung cancer.
    Eaton BR; Kim S; Marcus DM; Prabhu R; Chen Z; Ramalingam SS; Curran WJ; Higgins KA
    Cancer; 2013 Nov; 119(21):3753-60. PubMed ID: 23921891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prophylactic cranial irradiation in operable stage IIIA non small-cell lung cancer treated with neoadjuvant chemoradiotherapy: results from a German multicenter randomized trial.
    Pöttgen C; Eberhardt W; Grannass A; Korfee S; Stüben G; Teschler H; Stamatis G; Wagner H; Passlick B; Petersen V; Budach V; Wilhelm H; Wanke I; Hirche H; Wilke HJ; Stuschke M
    J Clin Oncol; 2007 Nov; 25(31):4987-92. PubMed ID: 17971598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prophylactic cranial irradiation after definitive chemoradiotherapy for limited-stage small cell lung cancer: Do all patients benefit?
    Farooqi AS; Holliday EB; Allen PK; Wei X; Cox JD; Komaki R
    Radiother Oncol; 2017 Feb; 122(2):307-312. PubMed ID: 28073578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylactic cranial irradiation in locally advanced non-small-cell lung cancer after multimodality treatment: long-term follow-up and investigations of late neuropsychologic effects.
    Stuschke M; Eberhardt W; Pöttgen C; Stamatis G; Wilke H; Stüben G; Stöblen F; Wilhelm HH; Menker H; Teschler H; Müller RD; Budach V; Seeber S; Sack H
    J Clin Oncol; 1999 Sep; 17(9):2700-9. PubMed ID: 10561344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors affecting the risk of brain metastases after definitive chemoradiation for locally advanced non-small-cell lung carcinoma.
    Robnett TJ; Machtay M; Stevenson JP; Algazy KM; Hahn SM
    J Clin Oncol; 2001 Mar; 19(5):1344-9. PubMed ID: 11230477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Role of Prophylactic Cranial Irradiation for Non-small Cell Lung Cancer.
    Precival C; Landy M; Poole C; Mullaney L
    Anticancer Res; 2018 Jan; 38(1):7-14. PubMed ID: 29277750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.